Cargando…

Patient-Reported Outcomes in Middle Ear and Active Transcutaneous Bone Conduction Hearing Implants

OBJECTIVE: This study used questionnaires to examine the patient-reported satisfaction with 2 hearing implant devices to determine the level of overall satisfaction with the devices, which, if any, factors predicted good or poor perceived outcomes, or whether there were any specific aspects of the d...

Descripción completa

Detalles Bibliográficos
Autores principales: E. M. Jones, Stephen, Roplekar-Bance, Rujuta, Green, Richard, Rae, Caroline, Ferguson, Aaron, M. Spielmann, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Academy of Otology and Neurotology and the Politzer Society 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975422/
https://www.ncbi.nlm.nih.gov/pubmed/34617890
http://dx.doi.org/10.5152/iao.2021.21077
_version_ 1784680377760088064
author E. M. Jones, Stephen
Roplekar-Bance, Rujuta
Green, Richard
Rae, Caroline
Ferguson, Aaron
M. Spielmann, Patrick
author_facet E. M. Jones, Stephen
Roplekar-Bance, Rujuta
Green, Richard
Rae, Caroline
Ferguson, Aaron
M. Spielmann, Patrick
author_sort E. M. Jones, Stephen
collection PubMed
description OBJECTIVE: This study used questionnaires to examine the patient-reported satisfaction with 2 hearing implant devices to determine the level of overall satisfaction with the devices, which, if any, factors predicted good or poor perceived outcomes, or whether there were any specific aspects of the devices where dissatisfaction was apparent. METHODS: A post-treatment questionnaire survey of 39 adult patients who had received a Vibrant Soundbridge (VSB) or Bonebridge (BB) hearing implant, with at least 3 months of follow-up, was conducted using the Glasgow Benefit Inventory (GBI) and Hearing Device Satisfaction Scale (HDSS). Satisfaction scores were compared to pre- and post-operative audiologic outcomes. The correlation between GBI and HDSS scores was also examined. RESULTS: A total of 28 of the 39 patients (72%) responded: 13 with a BB and 15 with a VSB at a mean of 13 months after implantation. The overall mean total GBI score was 30, with no significant differences across the groups. The responders generally reported that they were “satisfied” across most domains of the HDSS. In the study, 25 of the 28 responders were largely satisfied with their devices but 3 respondents were not. Two were known non-users, while one used the device but did not gain the benefit expected. It is instructive to note that all of these dissatisfied recipients were close to the manufacturer recommended limits for implantation of their respective devices at the time of surgery.
format Online
Article
Text
id pubmed-8975422
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Academy of Otology and Neurotology and the Politzer Society
record_format MEDLINE/PubMed
spelling pubmed-89754222022-04-14 Patient-Reported Outcomes in Middle Ear and Active Transcutaneous Bone Conduction Hearing Implants E. M. Jones, Stephen Roplekar-Bance, Rujuta Green, Richard Rae, Caroline Ferguson, Aaron M. Spielmann, Patrick J Int Adv Otol Original Article OBJECTIVE: This study used questionnaires to examine the patient-reported satisfaction with 2 hearing implant devices to determine the level of overall satisfaction with the devices, which, if any, factors predicted good or poor perceived outcomes, or whether there were any specific aspects of the devices where dissatisfaction was apparent. METHODS: A post-treatment questionnaire survey of 39 adult patients who had received a Vibrant Soundbridge (VSB) or Bonebridge (BB) hearing implant, with at least 3 months of follow-up, was conducted using the Glasgow Benefit Inventory (GBI) and Hearing Device Satisfaction Scale (HDSS). Satisfaction scores were compared to pre- and post-operative audiologic outcomes. The correlation between GBI and HDSS scores was also examined. RESULTS: A total of 28 of the 39 patients (72%) responded: 13 with a BB and 15 with a VSB at a mean of 13 months after implantation. The overall mean total GBI score was 30, with no significant differences across the groups. The responders generally reported that they were “satisfied” across most domains of the HDSS. In the study, 25 of the 28 responders were largely satisfied with their devices but 3 respondents were not. Two were known non-users, while one used the device but did not gain the benefit expected. It is instructive to note that all of these dissatisfied recipients were close to the manufacturer recommended limits for implantation of their respective devices at the time of surgery. European Academy of Otology and Neurotology and the Politzer Society 2021-09-01 /pmc/articles/PMC8975422/ /pubmed/34617890 http://dx.doi.org/10.5152/iao.2021.21077 Text en 2021 authors https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Article
E. M. Jones, Stephen
Roplekar-Bance, Rujuta
Green, Richard
Rae, Caroline
Ferguson, Aaron
M. Spielmann, Patrick
Patient-Reported Outcomes in Middle Ear and Active Transcutaneous Bone Conduction Hearing Implants
title Patient-Reported Outcomes in Middle Ear and Active Transcutaneous Bone Conduction Hearing Implants
title_full Patient-Reported Outcomes in Middle Ear and Active Transcutaneous Bone Conduction Hearing Implants
title_fullStr Patient-Reported Outcomes in Middle Ear and Active Transcutaneous Bone Conduction Hearing Implants
title_full_unstemmed Patient-Reported Outcomes in Middle Ear and Active Transcutaneous Bone Conduction Hearing Implants
title_short Patient-Reported Outcomes in Middle Ear and Active Transcutaneous Bone Conduction Hearing Implants
title_sort patient-reported outcomes in middle ear and active transcutaneous bone conduction hearing implants
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975422/
https://www.ncbi.nlm.nih.gov/pubmed/34617890
http://dx.doi.org/10.5152/iao.2021.21077
work_keys_str_mv AT emjonesstephen patientreportedoutcomesinmiddleearandactivetranscutaneousboneconductionhearingimplants
AT roplekarbancerujuta patientreportedoutcomesinmiddleearandactivetranscutaneousboneconductionhearingimplants
AT greenrichard patientreportedoutcomesinmiddleearandactivetranscutaneousboneconductionhearingimplants
AT raecaroline patientreportedoutcomesinmiddleearandactivetranscutaneousboneconductionhearingimplants
AT fergusonaaron patientreportedoutcomesinmiddleearandactivetranscutaneousboneconductionhearingimplants
AT mspielmannpatrick patientreportedoutcomesinmiddleearandactivetranscutaneousboneconductionhearingimplants